INQ000257098 – Press release from the Medicines and Healthcare products Regulatory Agency titled First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA, dated 04/11/2021.

  • Published: 8 September 2025
  • Type: Evidence
  • Module: Module 4

Press release from the Medicines and Healthcare products Regulatory Agency titled First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA, dated 04/11/2021.

Download this document